Caulis, Inc. (153A) AI Stock Analysis

• Market Cap: ¥9.37B
• Dividend Yield: N/A
• Average Volume (3M): 77.04K
• Price to Earnings (P/E): 28.5
• Beta (1Y): 1.31
• Revenue Growth: 14.92%
• EPS Growth: 2.55%
• Country: JP
• Employees: 42
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 11.22
• Shares Outstanding: 6,504,500
• 10 Day Avg. Volume: 150,880
• 30 Day Avg. Volume: 77,036
• PEG Ratio: -14.09
• Price to Book (P/B): 6.68
• Price to Sales (P/S): 7.17
• P/FCF Ratio: 33.04
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 66 Neutral
• Price Target: ¥1,555.00 ▼(-26.96% Downside)

Caulis, Inc. has a strong financial foundation with excellent profitability and growth potential, which is the most significant factor in its overall score. However, technical analysis indicates bearish momentum, and the valuation suggests the stock may be overvalued, which tempers the overall score.

Positive Factors

Revenue Growth

The company's significant revenue growth indicates increasing demand for its products and successful market penetration, supporting long-term business expansion.

Profitability

Strong profit margins reflect efficient cost management and pricing power, enhancing the company's ability to reinvest in growth and innovation.

Balance Sheet Health

Low leverage provides financial flexibility and reduces risk, allowing the company to pursue strategic opportunities without significant financial strain.

Negative Factors

Cash Flow Fluctuations

Fluctuations in cash flow, even if minor, can impact short-term liquidity and operational planning, necessitating careful cash management to maintain stability.

Stock Price Volatility

Bearish momentum in stock price can affect investor confidence and capital raising efforts, potentially impacting long-term strategic initiatives.

Valuation Concerns

High valuation ratios can limit upside potential and make the stock less attractive to value-focused investors, potentially impacting market perception.

Caulis, Inc. Business Overview & Revenue Model

Company Description

Caulis, Inc. (153A) is a biotechnology company specializing in the development of innovative agricultural solutions and biopesticides aimed at enhancing crop productivity and sustainability. The company focuses on harnessing natural plant-based compounds and advanced biotechnological methods to create products that protect crops from pests and diseases while minimizing environmental impact. Caulis, Inc. operates primarily within the agricultural sector, catering to farmers and agricultural businesses seeking eco-friendly alternatives to traditional chemical pesticides.

How the Company Makes Money

Caulis, Inc. generates revenue through multiple key streams, primarily from the sale of its biopesticide products to agricultural distributors and directly to farmers. The company also engages in research and development collaborations with agricultural firms and universities, which can lead to sponsored research agreements and licensing deals for its proprietary technologies. Additionally, Caulis, Inc. may receive grants and funding from government and non-governmental organizations focused on sustainable agriculture initiatives. Strategic partnerships with larger agricultural companies enhance its market reach and distribution capabilities, contributing significantly to its earnings.

Caulis, Inc. Financial Statement Overview

Summary

Caulis, Inc. exhibits strong financial performance with impressive revenue growth, robust profitability margins, and efficient cash management. The company maintains a healthy balance sheet with low leverage and high equity, supporting its growth and operational strategies.

Income Statement

Caulis, Inc. has demonstrated strong revenue growth with a 23.1% increase from 2023 to 2024. The gross profit margin is robust at 63.3%, and the net profit margin is healthy at 22.6%. The EBIT margin of 33.7% and EBITDA margin of 32.2% indicate efficient operational management. Overall, the company shows excellent profitability and growth trajectory.

Balance Sheet

The company's balance sheet is strong, with a low debt-to-equity ratio of 0.19, indicating low leverage. The return on equity is impressive at 21.0%, reflecting effective use of equity capital. The equity ratio of 65.0% suggests a solid financial structure with a high proportion of equity financing. However, the decrease in total liabilities and increase in stockholders' equity highlight improved financial health.

Cash Flow

Caulis, Inc. has shown a stable cash flow position with a slight decrease in operating cash flow. The free cash flow to net income ratio is strong, indicating efficient cash generation relative to net income. The operating cash flow to net income ratio is also favorable, suggesting good cash conversion. Overall, the cash flow metrics reflect a solid cash management strategy.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	670.56M	1.23B	995.00M	769.47M	489.21M
Gross Profit	422.33M	774.96M	613.46M	495.40M	254.37M
EBITDA	225.14M	394.62M	302.29M	225.93M	20.00M
Net Income	145.63M	276.30M	260.37M	249.96M	13.46M
Balance Sheet
Total Assets	2.21B	2.02B	1.18B	718.30M	481.51M
Cash, Cash Equivalents and Short-Term Investments	1.88B	1.73B	954.70M	604.11M	431.24M
Total Debt	250.00M	250.00M	301.00M	250.00M	290.00M
Total Liabilities	745.17M	708.52M	727.04M	527.01M	538.44M
Stockholders Equity	1.47B	1.32B	451.66M	191.28M	-56.93M
Cash Flow
Free Cash Flow	0.00	265.90M	299.58M	212.86M	117.33M
Operating Cash Flow	0.00	266.22M	306.55M	215.42M	119.36M
Investing Cash Flow	0.00	-322.00K	-6.95M	-2.56M	-2.02M
Financing Cash Flow	0.00	512.50M	51.00M	-40.00M	-2.50M

Caulis, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2129.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:153A, the sentiment is Negative. The current price of 2129 is above the 20-day moving average (MA) of 1705.85, above the 50-day MA of 2054.82, and above the 200-day MA of 1663.22, indicating a bearish trend. The MACD of -211.02 indicates Positive momentum. The RSI at 31.25 is Neutral, neither overbought nor oversold. The STOCH value of 34.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:153A.

Caulis, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4284	79 Outperform	¥10.55B	13.99	―	2.44%	9.77%	93.99%
4495	78 Outperform	¥14.87B	22.54	―	1.21%	23.67%	24.95%
4389	67 Neutral	¥9.12B	14.94	―	1.48%	17.83%	34.25%
153A	66 Neutral	¥9.37B	28.55	―	―	14.92%	2.55%
4168	64 Neutral	¥12.32B	16.36	―	0.64%	9.78%	-23.98%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
3853	61 Neutral	¥18.65B	16.40	―	0.63%	―	―